Alteplase for Code with high suspicion for PE

PLEASE NOTE: Posts made to this forum should not be considered as the expressed opinions of, nor should be considered endorsed by, the Medication Safety Officer’s Society (MSOS) or the Institute for Safe Medication Practices (ISMP).

Make sure your email is up-to-date
In order to continue to receive updates from MSOS, as well as forum posts and other valuable information as a member of MSOS, please be sure to update your email address with us, whenever it changes. If you need assistance doing so, please send an email to jrufo@ismp.org.

1 post / 0 new

Mon, 11/01/2021 - 08:15

Julie A DAmbrosi

Offline

Last seen: 1 week 2 days ago

Joined: 07/22/2017 - 06:53

Alteplase for Code with high suspicion for PE

New recommendations allow for a second 50 mg IVP dose of alteplase in patients in cardiac arrest with known or high suspicion for PE, who had objective evidence response to the first alteplase 50 mg IVP dose but did not sustain ROSC. Pharmacy currently prepares the first 50 mg IVP, outside of our system ED locations, in a syringe as ready-to-administer with goal availability from request to delivery of <15 min. With anticipated second dose being given 15 min after the first dose, if there is evidence of partial response, we are wondering how other institutions operationalize their response.

Do you have 24/7 pharmacist participation in codes?
Do you have a member of the code response bring an alteplase kit to every code OR retrieve the kit when there is high suspicion of PE?
If yes, what are the contents of the kit?
How do you ensure the second dose is indicated?
How do you ensure a 15 min interval between first and second dose?

Members Log In